Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors
Sachithra Thazhathuveedu Sudevan, T. M. Rangarajan, Abdullah G. Al‐Sehemi, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 8
Closed Access | Times Cited: 20

Showing 20 citing articles:

Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect
Sunil Kumar, Jong‐Min Oh, P. Prabitha, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors
Sunil Kumar, Ratul Bhowmik, Jong‐Min Oh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Morpholino Pyridazinone Derivatives as Selective Mao-B Inhibitors
Yaren Nur Zenni, Zeynep Özdemir, Selma Saraç, et al.
(2025)
Closed Access
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities
Jaydeep A. Mokariya, Dhanji P. Rajani, Manish P. Patel
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 22
Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors
Jayalakshmi Jayan, Namitha Chandran, Amrutha Chandran Thekkantavida, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 37731-37751
Open Access | Times Cited: 11
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
Jiseong Lee, Saranya Kattil Parmbil, Nagendar Kumar Pandit, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8
One-pot synthesis of tetrahydropyrimidinecarboxamides enabling in vitro anticancer activity: a combinative study with clinically relevant brain-penetrant drugs
Dipti B. Upadhyay, Joaquina Nogales, Jaydeep A. Mokariya, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27174-27186
Open Access | Times Cited: 2
Inhibition of monoamine oxidases by heterocyclic derived conjugated dienones: synthesis, in vitro, and in silico investigations
Sunil Kumar, Bishnu Prasad Pandey, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones
Ashutosh Kumar Singh, Seong‐Min Kim, Jong‐Min Oh, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 271-284
Open Access | Times Cited: 5
Insights of structure-based virtual screening and MPO-based SAR analysis of berberine-benzimidazole derivatives against Parkinson disease
Victor Moreira de Oliveira, Matheus Nunes da Rocha, Caio Henrique Alexandre Roberto, et al.
Journal of Molecular Structure (2023) Vol. 1302, pp. 137453-137453
Closed Access | Times Cited: 5
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents
Ahmed H.E. Hassan, Yeonwoo Choi, Rium Kim, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117826-117826
Closed Access | Times Cited: 1
Discovery of novel 2-(4-(benzyloxy)-5-(hydroxyl) phenyl) benzothiazole derivatives as multifunctional MAO-B inhibitors for the treatment of Parkinson’s disease
Zhongcheng Cao, Xingyue Wang, Tianlong Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease
Valentin Karabelyov, Violina T. Angelova, Martin Sharkov, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135755-135755
Closed Access | Times Cited: 3
Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment
Feba Benny, Jong‐Min Oh, Sunil Kumar, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35240-35250
Open Access | Times Cited: 3
Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders
Princika Srivastava, Sachithra Thazhathuveedu Sudevan, Thennavan Arumugam, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 331-341
Closed Access | Times Cited: 2
1,2,3-Triazole based xanthene and acridine linkers as potential α-glucosidase and α-amylase inhibitors: design, green synthesis, kinetics, and in silico studies
Reena C. Patel, Chetan V. Rajput, Manish P. Patel
Journal of Molecular Structure (2024), pp. 141196-141196
Closed Access
New class of thio/semicarbazide-based benzyloxy derivatives as selective class of monoamine oxidase-B inhibitors
Namitha Chandran, Jiseong Lee, P. Prabitha, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
2‐Hydroxy‐4‐benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease
Zhongcheng Cao, Tianlong Zhang, Xianwu Fu, et al.
ChemMedChem (2023) Vol. 18, Iss. 6
Closed Access | Times Cited: 1
Page 1

Scroll to top